| Old Articles: <Older 5451-5460 Newer> |
|---|
 |
The Motley Fool
January 27, 2005
Rick Aristotle Munarriz |
Milkshakes Better Than Yours Steak 'n Shake mixes things up in a good way for another steady yet strong holiday quarter.   |
The Motley Fool
January 26, 2005
John Bluis |
Genzyme Feels the Heat Drug company faces first true competition to its enzyme replacement therapy for Gaucher disease. |
The Motley Fool
January 26, 2005
Stephen D. Simpson |
Sanofi's Balancing Act A broad portfolio of drugs helps the French pharmaceutical stay ahead of its peers. It's a good option for investors who want a strong growth stock in the pharmaceutical space but don't want to take on the risks of turnarounds or litigation. |
The Motley Fool
January 26, 2005
W.D. Crotty |
Cut the Carbs Compared with other food stocks, American Italian Pasta isn't worth its premium. |
The Motley Fool
January 26, 2005
Jeff Hwang |
EA's Cool Holiday Quarter Game maker held its own in a crowded Christmas-season marketplace. Investors, take note. |
The Motley Fool
January 26, 2005
Ben McClure |
Tellabs Hardly Inspires Competition makes for a dreary outlook for the telecom equipment maker. |
The Motley Fool
January 26, 2005
Charly Travers |
Call Cubist in the Morning Strong drug sales provide a dose of good medicine for this pharmaceutical. |
The Motley Fool
January 26, 2005
Charly Travers |
Protein Design Muscles Up Biotech company buys itself a bigger future. The company announced that it had acquired privately held ESP Pharma for $300 million cash and $175 million stock. |
The Motley Fool
January 26, 2005
Nathan Slaughter |
Hershey's Sweet Growth With a little help from new products, the candy leader posts record Q4 earnings. |
The Motley Fool
January 26, 2005
Stephen D. Simpson |
St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains. |
| <Older 5451-5460 Newer> Return to current articles. |
